While APOE4 deleteriously affects the pathogenesis of comorbidities that influence the severity of COVID-19, such as dementia, hypertension, and heart disease, paradoxically, APOE4 may be a protective factor against the chronicity of most liver diseases, which could lead to more severe conditions of COVID-19. This evidence concerns the gene APOE and hypertensive disorder.